Fanconi Anemia, Complementation Group L (FANCL) Peptide
FANCL
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target See all FANCL products
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- ASGREHLITL KLKAKYPAES PDYFVDFPVP FCASWTPQVN SPQSSLISIY
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FANCL antibody,
Alternative Names: FANCL control peptide, FANCL antibody Blocking Peptide, Anti-FANCL Blocking Peptide, Fanconi Anemia Complementation Group L Blocking Peptide, FAAP43 Blocking Peptide, FLJ10335 Blocking Peptide, PHF9 Blocking Peptide, POG Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- FANCL (Fanconi Anemia, Complementation Group L (FANCL))
- Synonyms
- FAAP43 Peptide, PHF9 Peptide, POG Peptide, 2010322C19Rik Peptide, AW554273 Peptide, B230118H11Rik Peptide, Phf9 Peptide, Pog Peptide, gcd Peptide, Fanconi anemia complementation group L Peptide, Fanconi anemia, complementation group L Peptide, FANCL Peptide, Fancl Peptide
- Background
- The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM and FANCN. The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair.
- Molecular Weight
- 42 kDa
-
You are here:
